Ekso Bionics Holdings Inc (OQ:EKSO)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 1414 Harbour Way S Ste 1201
RICHMOND CA 94804-3628
Tel: 1-212-8671768
Website: https://ir.eksobionics.com
IR: See website
<
Key People
Steven A. Sherman
Executive Chairman of the Board
Jack Peurach
President, Chief Executive Officer, Director
John F. Glenn
Chief Financial Officer, Secretary
William R. Shaw
Chief Commercial Officer
   
Business Overview
Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.
Financial Overview
For the three months ended 31 March 2020, Ekso Bionics Holdings Inc revenues decreased 59% to $1.5M. Net loss decreased 61% to $2.5M. Revenues reflect EksoHealth segment decrease of 58% to $1.2M, EksoWorks segment decrease of 65% to $277K, United States segment decrease of 47% to $1.2M, All other segment decrease of 82% to $219K. Lower net loss reflects FV Adjustments of Financial Investments increase from $1.1M (expense) to $2.5M
Employees: 67 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $60.84M as of Mar 31, 2020
Annual revenue (TTM): $11.77M as of Mar 31, 2020
EBITDA (TTM): -$15.90M as of Mar 31, 2020
Net annual income (TTM): -$8.12M as of Mar 31, 2020
Free cash flow (TTM): -$12.37M as of Mar 31, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 7,591,146 as of Jun 7, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization